MA
XBI icon

MYDA Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

MYDA Advisors’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-5,000
Closed -$359K – 141
2018
Q4 		$359K Buy
+5,000
New +$403K 0.62% 41

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

MYDA Advisors's XBI Position: Q4 2023 in Review

MYDA Advisors sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2023, closing a stake of 28,000 shares — an estimated $2.04M sold.

MYDA Advisors first reported a position in XBI in Q4 2017 and held it in 8 quarters. The position peaked at $3.81M in Q4 2021. 745 funds tracked by Wall St. Rank hold XBI as of Q4 2023.

  • MYDA Advisors reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2023 after selling out during the quarter.
  • MYDA Advisors sold 28,000 State Street SPDR S&P Biotech ETF shares in Q4 2023, an estimated $2.04M.
  • MYDA Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q4 2017 and held it in 8 quarters.
  • MYDA Advisors's State Street SPDR S&P Biotech ETF position peaked at $3.81M in Q4 2021.
  • 745 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2023.

Based on MYDA Advisors's 13F filing for Q4 2023, filed 13 Feb 2024.